With the current pandemic crisis, the lack of worldwide vaccine manufacturing capacity has become a serious concern. ContiVir, a spin-off project at the Max Planck Institute for Dynamics of Complex Technical Systems Magdeburg, has successfully produced a virus-like particle as a COVID-19 vaccine candidate, using a fully scalable system for quick vaccine manufacturing in large scales. The technologies and processes have been developed by Dr.-Ing. Felipe Tapia und Dr.-Ing. Pavel Marichal-Gallardo, members of the Bioprocess Engineering group (headed by Prof. Dr.-Ing. Udo Reichl).